astrazeneca hit by drug failure shares in anglo swedish drug have closed down 8 in uk trade after the failure of its iressa drug in a major clinical trial. this would be two of the three blockbuster drugs that were meant to power the company forward failing... and we ve got risks on crestor said nick turner analyst at brokers jefferies. tarceva made by osi pharmaceuticals genentech and roche has already proved to be successful in helping prolong the life of lung cancer patients. i am determined to improve our development and regulatory performance restore confidence in the company and value to shareholders said chief executive tom mckillop. meanwhile another of its major money spinners cholesterol drug crestor is facing mounting safety concerns.